PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27585443-8	2017	Besides, Oroxylin A could obviously radiosensitize ESCC cells by arresting tumor cells in G2/M phase and regulating cyclin B1 and Cdc 2 protein expression.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	9-19	cyclin dependent kinase 1	Homo sapiens	130-135	
18957166-0	2008	Oroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	0-10	cyclin dependent kinase 1	Homo sapiens	91-95	
18957166-4	2008	Western blot analysis demonstrated that oroxylin A-induced cell-cycle arrest in BGC-823 cells was associated with a significant decrease in cdc2/p34, cyclin B1 and cyclin A expression.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	40-50	cyclin dependent kinase 1	Homo sapiens	140-144	
18957166-5	2008	In addition, oroxylin A-treated cells decreased the expression of Cdk7, which was responsible for the low expression of M phase promoting factor (cyclin B1/Cdc2).	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	13-23	cyclin dependent kinase 1	Homo sapiens	156-160	
18957166-6	2008	The results suggested that oroxylin A induced G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	27-37	cyclin dependent kinase 1	Homo sapiens	118-122